BifurcAID vs MCSAID
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
BifurcAID
This educational tool provides step-by-step visual guidance for performing coronary bifurcation interventions. It is designed to help medical professionals learn and practice complex procedures.
- Step-by-step illustrations
- Coronary bifurcation intervention guidance
- Educational tool for medical professionals
- Visual learning aid
Read full descriptionHide full description
BifurcAID is an educational tool with step by step illustrations of how to perform coronary bifurcation interventions.
MCSAID
Read full descriptionHide full description
MCSAID is an educational application dedicated to the topic of mechanical cardiocirculatory support for patients with cardiogenic shock. A basic section introduces the definitions and classifications of cardiogenic shock as well as some of the common devices used for hemodynamic support in unstable patients. There is an algorithm for helping understand the decision process depending on key clinical variables such as cardiac output and PAPI. There are also several weaning and escalation algorithm. A calculator section is available for some common hemodynamic variables used in MCS decision-making and is available for quick-reference throughout the algorithm. MCSAID is an educational application for medical professionals and is not intended for making medical diagnoses. Medical decisions must be made by licensed professionals with the entire context of a patient’s medical history. If you are seeking a medical diagnosis, contact your physician and if you are experiencing a medical emergency, call your local emergency medical services.
Screenshots
Verdict
The clearest difference is update cadence: BifurcAID at every 3 months against MCSAID's every 40 months. BifurcAID also leads on iOS requirement (13.0 vs 15.0). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
BifurcAID ships an update every 3 months, MCSAID every 40 months. The most recent releases landed on October 6, 2026 and September 12, 2026 respectively.
| Parameter | BifurcAID | MCSAID |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (16 ratings) — better | — |
| Positive reviews | 100.0% of reviews | — |
| Number of ratings | 16 — better | — |
| Update frequency | Every 3 months — better | Every 40 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod — better | iPhone, iPod |
| Requires iOS | 13.0 — better | 15.0 |
| Further details — not scored | ||
| Size | 55 MB | 46 MB |
| Age rating | 17+ | 17+ |
| Developer | Icahn School of Medicine at Mount Sinai | Cardiology Apps LLC |
In-app purchases
BifurcAID
No in-app purchases
MCSAID
No in-app purchases








